U.S. stocks surge | Q2 revenue and profits exceed expectations, Abbott (ABT.US) rises over 12%

According to the 36Kr Finance APP, on Thursday, the stock price of Abbott Laboratories (ABT.US) rose, with the stock up over 12% to $99.96 as of the time of writing. The financial report shows that Abbott's second-quarter revenue was $12.59 billion, an increase of 13.0% year-on-year, exceeding market expectations; adjusted earnings per share were $1.31, surpassing expectations by $0.03. The company stated in a statement on Thursday that it now expects adjusted earnings per share for the year to be between $5.45 and $5.60, with the midpoint increasing by 5 cents; the company reaffirmed its full-year same-store sales growth forecast for 2026 at 6.5% to 7.5%.